

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 8.03073776 |
| 2 | negative thymic T cell selection (GO:0045060) | 7.17443059 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.90919231 |
| 4 | positive T cell selection (GO:0043368) | 6.59882673 |
| 5 | cytidine deamination (GO:0009972) | 6.53349110 |
| 6 | cytidine metabolic process (GO:0046087) | 6.53349110 |
| 7 | cytidine catabolic process (GO:0006216) | 6.53349110 |
| 8 | regulation of regulatory T cell differentiation (GO:0045589) | 6.45443511 |
| 9 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.38330964 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.32308921 |
| 11 | tolerance induction (GO:0002507) | 6.25994949 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.13141038 |
| 13 | positive thymic T cell selection (GO:0045059) | 6.12723865 |
| 14 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.12683300 |
| 15 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 6.02067111 |
| 16 | DNA deamination (GO:0045006) | 5.95987835 |
| 17 | thymic T cell selection (GO:0045061) | 5.94199674 |
| 18 | cellular response to interleukin-15 (GO:0071350) | 5.84367507 |
| 19 | negative regulation of cell killing (GO:0031342) | 5.80865089 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.80865089 |
| 21 | regulation of T cell tolerance induction (GO:0002664) | 5.71595426 |
| 22 | T cell selection (GO:0045058) | 5.66412176 |
| 23 | positive regulation of tolerance induction (GO:0002645) | 5.51240361 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 5.46744647 |
| 25 | response to interleukin-15 (GO:0070672) | 5.28723139 |
| 26 | leukocyte aggregation (GO:0070486) | 5.22651591 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.94669948 |
| 28 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.87358910 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.84208692 |
| 30 | regulation of tolerance induction (GO:0002643) | 4.70746074 |
| 31 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.53791562 |
| 32 | regulation of isotype switching to IgG isotypes (GO:0048302) | 4.46977630 |
| 33 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.43868564 |
| 34 | negative regulation of T cell mediated immunity (GO:0002710) | 4.36236002 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.36103695 |
| 36 | positive regulation of granulocyte differentiation (GO:0030854) | 4.33004975 |
| 37 | T cell receptor signaling pathway (GO:0050852) | 4.32743970 |
| 38 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.32454063 |
| 39 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.32454063 |
| 40 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.29709440 |
| 41 | T cell migration (GO:0072678) | 4.28605629 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 4.27019917 |
| 43 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.24546709 |
| 44 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.20959522 |
| 45 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 4.20053151 |
| 46 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.14928503 |
| 47 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.12910044 |
| 48 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.11198517 |
| 49 | activated T cell proliferation (GO:0050798) | 4.10986157 |
| 50 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 4.03394372 |
| 51 | regulation of B cell differentiation (GO:0045577) | 3.99231860 |
| 52 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.95569829 |
| 53 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.95342816 |
| 54 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.94606974 |
| 55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.85566061 |
| 56 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.84533107 |
| 57 | positive regulation of cell killing (GO:0031343) | 3.81808801 |
| 58 | positive regulation of defense response to virus by host (GO:0002230) | 3.76490568 |
| 59 | T cell costimulation (GO:0031295) | 3.74798666 |
| 60 | regulation of cell killing (GO:0031341) | 3.70716963 |
| 61 | lymphocyte costimulation (GO:0031294) | 3.70222849 |
| 62 | interferon-gamma production (GO:0032609) | 3.65997827 |
| 63 | mast cell activation (GO:0045576) | 3.65658187 |
| 64 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.62661714 |
| 65 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.58749405 |
| 66 | T cell differentiation (GO:0030217) | 3.52677149 |
| 67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.50579635 |
| 68 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.45911641 |
| 69 | negative regulation of viral genome replication (GO:0045071) | 3.45314012 |
| 70 | positive regulation of T cell differentiation in thymus (GO:0033089) | 3.44750709 |
| 71 | alpha-beta T cell differentiation (GO:0046632) | 3.41836270 |
| 72 | type I interferon signaling pathway (GO:0060337) | 3.39912158 |
| 73 | cellular response to type I interferon (GO:0071357) | 3.39912158 |
| 74 | response to type I interferon (GO:0034340) | 3.35543507 |
| 75 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.32021484 |
| 76 | T-helper cell differentiation (GO:0042093) | 3.32021484 |
| 77 | positive regulation of interleukin-4 production (GO:0032753) | 3.31609005 |
| 78 | negative regulation of T cell apoptotic process (GO:0070233) | 3.25936380 |
| 79 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.22240678 |
| 80 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.18080605 |
| 81 | positive regulation of humoral immune response (GO:0002922) | 3.16898869 |
| 82 | lymphocyte migration (GO:0072676) | 3.15257970 |
| 83 | actin nucleation (GO:0045010) | 3.13963420 |
| 84 | positive regulation of T cell mediated immunity (GO:0002711) | 3.13675498 |
| 85 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.13232094 |
| 86 | alpha-beta T cell activation involved in immune response (GO:0002287) | 3.13232094 |
| 87 | T cell differentiation involved in immune response (GO:0002292) | 3.13232094 |
| 88 | T cell activation (GO:0042110) | 3.11380887 |
| 89 | alpha-beta T cell activation (GO:0046631) | 3.08561329 |
| 90 | regulation of defense response to virus by virus (GO:0050690) | 3.06804237 |
| 91 | regulation of alpha-beta T cell activation (GO:0046634) | 3.04902101 |
| 92 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.04809613 |
| 93 | positive regulation of alpha-beta T cell activation (GO:0046635) | 3.04049184 |
| 94 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.00828555 |
| 95 | dendritic cell chemotaxis (GO:0002407) | 3.00511722 |
| 96 | T cell homeostasis (GO:0043029) | 2.98870300 |
| 97 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.98353311 |
| 98 | B cell receptor signaling pathway (GO:0050853) | 2.96833116 |
| 99 | mast cell degranulation (GO:0043303) | 2.96143245 |
| 100 | mast cell activation involved in immune response (GO:0002279) | 2.96143245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.39416398 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 6.65993765 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.60119305 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.45595704 |
| 5 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.34876424 |
| 6 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.89170730 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.71417959 |
| 8 | MYB_26560356_Chip-Seq_TH2_Human | 3.58125649 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.28560627 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.28054879 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.18575885 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.07253535 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.98535288 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.80213039 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.78909311 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.77571916 |
| 17 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.77015387 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.69948835 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.61404506 |
| 20 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.51395498 |
| 21 | UTX_26944678_Chip-Seq_JUKART_Human | 2.43598222 |
| 22 | GATA3_26560356_Chip-Seq_TH2_Human | 2.32238029 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 2.31522172 |
| 24 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.18572445 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15455349 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.88455563 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86074838 |
| 28 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.81013774 |
| 29 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.78980697 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.72385850 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.68082503 |
| 32 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64220858 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61364151 |
| 34 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.59421798 |
| 35 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.58786864 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57344523 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.54707303 |
| 38 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.46855154 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.38416527 |
| 40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34651908 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31679334 |
| 42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.30604918 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.30150902 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22598662 |
| 45 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22219058 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.21235448 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.20229882 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18085959 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13695033 |
| 50 | GATA3_26560356_Chip-Seq_TH1_Human | 1.12846723 |
| 51 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10204157 |
| 52 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07931285 |
| 53 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.07709690 |
| 54 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.07502237 |
| 55 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07360898 |
| 56 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07277195 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.05878519 |
| 58 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.03575287 |
| 59 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03232808 |
| 60 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02325933 |
| 61 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01410164 |
| 62 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01038633 |
| 63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98512787 |
| 64 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.98235283 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94792228 |
| 66 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92558565 |
| 67 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92041026 |
| 68 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88633194 |
| 69 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86425794 |
| 70 | P300_27268052_Chip-Seq_Bcells_Human | 0.86257020 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85789629 |
| 72 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.85275539 |
| 73 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84744621 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84507678 |
| 75 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.82783647 |
| 76 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.80388395 |
| 77 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79797487 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78713273 |
| 79 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.77479380 |
| 80 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.76532161 |
| 81 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.76242454 |
| 82 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74855825 |
| 83 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.74135418 |
| 84 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.72243166 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.70971194 |
| 86 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.69943454 |
| 87 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.69605883 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.69434652 |
| 89 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.68471979 |
| 90 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.68465666 |
| 91 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.68308430 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.68113995 |
| 93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.67782247 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.67575767 |
| 95 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.67256871 |
| 96 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.65579255 |
| 97 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.64666946 |
| 98 | SA1_27219007_Chip-Seq_Bcells_Human | 0.64098975 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.64048644 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.63846362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.36520565 |
| 2 | MP0003763_abnormal_thymus_physiology | 4.68466494 |
| 3 | MP0001873_stomach_inflammation | 3.96696476 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.66260396 |
| 5 | MP0009333_abnormal_splenocyte_physiolog | 3.40340067 |
| 6 | MP0001800_abnormal_humoral_immune | 3.31540417 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.20072043 |
| 8 | MP0003436_decreased_susceptibility_to | 3.14883631 |
| 9 | MP0002166_altered_tumor_susceptibility | 3.08659123 |
| 10 | MP0003724_increased_susceptibility_to | 2.94243342 |
| 11 | MP0002420_abnormal_adaptive_immunity | 2.77159443 |
| 12 | MP0001790_abnormal_immune_system | 2.74623077 |
| 13 | MP0005387_immune_system_phenotype | 2.74623077 |
| 14 | MP0002723_abnormal_immune_serum | 2.72537888 |
| 15 | MP0009785_altered_susceptibility_to | 2.71846393 |
| 16 | MP0001819_abnormal_immune_cell | 2.70819380 |
| 17 | MP0000685_abnormal_immune_system | 2.56869465 |
| 18 | MP0003866_abnormal_defecation | 2.54081174 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.47699803 |
| 20 | MP0005025_abnormal_response_to | 2.47417797 |
| 21 | MP0002405_respiratory_system_inflammati | 2.37647214 |
| 22 | MP0002398_abnormal_bone_marrow | 2.37107708 |
| 23 | MP0000703_abnormal_thymus_morphology | 2.34319522 |
| 24 | MP0002148_abnormal_hypersensitivity_rea | 2.32046977 |
| 25 | MP0010155_abnormal_intestine_physiology | 2.30546074 |
| 26 | MP0002006_tumorigenesis | 2.28092882 |
| 27 | MP0000716_abnormal_immune_system | 2.27348545 |
| 28 | MP0006082_CNS_inflammation | 2.14505461 |
| 29 | MP0002009_preneoplasia | 2.07574899 |
| 30 | MP0004947_skin_inflammation | 2.03176502 |
| 31 | MP0002419_abnormal_innate_immunity | 1.98566816 |
| 32 | MP0000689_abnormal_spleen_morphology | 1.95198686 |
| 33 | MP0005310_abnormal_salivary_gland | 1.94949817 |
| 34 | MP0002933_joint_inflammation | 1.94579687 |
| 35 | MP0002722_abnormal_immune_system | 1.86825634 |
| 36 | MP0004381_abnormal_hair_follicle | 1.85595182 |
| 37 | MP0001853_heart_inflammation | 1.85189259 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.75895375 |
| 39 | MP0002429_abnormal_blood_cell | 1.73743795 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.67424086 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.66040591 |
| 42 | MP0002163_abnormal_gland_morphology | 1.61283936 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.58170679 |
| 44 | MP0001533_abnormal_skeleton_physiology | 1.40663263 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.38873321 |
| 46 | MP0008469_abnormal_protein_level | 1.29627384 |
| 47 | MP0003806_abnormal_nucleotide_metabolis | 1.26565431 |
| 48 | MP0003300_gastrointestinal_ulcer | 1.25890106 |
| 49 | MP0000490_abnormal_crypts_of | 1.25603209 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.25228438 |
| 51 | MP0001663_abnormal_digestive_system | 1.15293132 |
| 52 | MP0001919_abnormal_reproductive_system | 1.14916940 |
| 53 | MP0009764_decreased_sensitivity_to | 1.11213600 |
| 54 | MP0001851_eye_inflammation | 1.07812982 |
| 55 | MP0003303_peritoneal_inflammation | 1.02391234 |
| 56 | MP0001348_abnormal_lacrimal_gland | 0.96283028 |
| 57 | MP0003448_altered_tumor_morphology | 0.93809443 |
| 58 | MP0000372_irregular_coat_pigmentation | 0.92730013 |
| 59 | MP0000858_altered_metastatic_potential | 0.92012032 |
| 60 | MP0005360_urolithiasis | 0.91343172 |
| 61 | MP0009763_increased_sensitivity_to | 0.88736960 |
| 62 | MP0004510_myositis | 0.86608938 |
| 63 | MP0002693_abnormal_pancreas_physiology | 0.85601281 |
| 64 | MP0002019_abnormal_tumor_incidence | 0.85016309 |
| 65 | MP0008995_early_reproductive_senescence | 0.83325325 |
| 66 | MP0002132_abnormal_respiratory_system | 0.81252589 |
| 67 | MP0002396_abnormal_hematopoietic_system | 0.78308448 |
| 68 | MP0005379_endocrine/exocrine_gland_phen | 0.77618350 |
| 69 | MP0003787_abnormal_imprinting | 0.72017746 |
| 70 | MP0002254_reproductive_system_inflammat | 0.69764018 |
| 71 | MP0003045_fibrosis | 0.69306780 |
| 72 | MP0002998_abnormal_bone_remodeling | 0.68394768 |
| 73 | MP0005381_digestive/alimentary_phenotyp | 0.66288528 |
| 74 | MP0003786_premature_aging | 0.65744068 |
| 75 | MP0001765_abnormal_ion_homeostasis | 0.64891729 |
| 76 | MP0003252_abnormal_bile_duct | 0.63389075 |
| 77 | MP0005166_decreased_susceptibility_to | 0.61028747 |
| 78 | MP0001346_abnormal_lacrimal_gland | 0.59731896 |
| 79 | MP0008873_increased_physiological_sensi | 0.57048729 |
| 80 | MP0005645_abnormal_hypothalamus_physiol | 0.56314233 |
| 81 | MP0003191_abnormal_cellular_cholesterol | 0.51484904 |
| 82 | MP0009765_abnormal_xenobiotic_induced | 0.50417505 |
| 83 | MP0001501_abnormal_sleep_pattern | 0.50318602 |
| 84 | MP0005390_skeleton_phenotype | 0.49420103 |
| 85 | MP0000604_amyloidosis | 0.49260285 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.48666733 |
| 87 | MP0005389_reproductive_system_phenotype | 0.47699196 |
| 88 | MP0000477_abnormal_intestine_morphology | 0.46538764 |
| 89 | MP0009643_abnormal_urine_homeostasis | 0.44749590 |
| 90 | MP0004883_abnormal_blood_vessel | 0.44263254 |
| 91 | MP0000249_abnormal_blood_vessel | 0.43482252 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.43156953 |
| 93 | MP0001764_abnormal_homeostasis | 0.41713446 |
| 94 | MP0003795_abnormal_bone_structure | 0.40083091 |
| 95 | MP0000609_abnormal_liver_physiology | 0.38663595 |
| 96 | MP0008872_abnormal_physiological_respon | 0.37724977 |
| 97 | MP0003172_abnormal_lysosome_physiology | 0.37434099 |
| 98 | MP0005636_abnormal_mineral_homeostasis | 0.36940059 |
| 99 | MP0001191_abnormal_skin_condition | 0.35629874 |
| 100 | MP0009642_abnormal_blood_homeostasis | 0.34497154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 7.19762607 |
| 2 | Abnormality of T cell number (HP:0011839) | 6.75211064 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.74534207 |
| 4 | Severe combined immunodeficiency (HP:0004430) | 5.90181985 |
| 5 | Autoimmune hemolytic anemia (HP:0001890) | 5.65400820 |
| 6 | Abnormality of T cells (HP:0002843) | 5.11979000 |
| 7 | Stomatitis (HP:0010280) | 5.01584773 |
| 8 | IgG deficiency (HP:0004315) | 4.92768452 |
| 9 | Combined immunodeficiency (HP:0005387) | 4.66776336 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.30948825 |
| 11 | Myositis (HP:0100614) | 4.06037600 |
| 12 | Chronic diarrhea (HP:0002028) | 4.05644585 |
| 13 | Increased IgM level (HP:0003496) | 3.97673673 |
| 14 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.90109213 |
| 15 | Abnormality of eosinophils (HP:0001879) | 3.87638374 |
| 16 | Aplastic anemia (HP:0001915) | 3.85236317 |
| 17 | Optic neuritis (HP:0100653) | 3.76913544 |
| 18 | Retrobulbar optic neuritis (HP:0100654) | 3.76913544 |
| 19 | Recurrent fungal infections (HP:0002841) | 3.73296562 |
| 20 | Encephalitis (HP:0002383) | 3.66695034 |
| 21 | Recurrent bronchitis (HP:0002837) | 3.60638560 |
| 22 | Pulmonary infiltrates (HP:0002113) | 3.60537605 |
| 23 | Slow saccadic eye movements (HP:0000514) | 3.53867804 |
| 24 | Abnormality of T cell physiology (HP:0011840) | 3.50038708 |
| 25 | Thyroiditis (HP:0100646) | 3.48950660 |
| 26 | Orchitis (HP:0100796) | 3.44357458 |
| 27 | Panhypogammaglobulinemia (HP:0003139) | 3.42226304 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.41388910 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.41388910 |
| 30 | Meningitis (HP:0001287) | 3.40149122 |
| 31 | Gastrointestinal infarctions (HP:0005244) | 3.36449796 |
| 32 | Eosinophilia (HP:0001880) | 3.33998559 |
| 33 | Vasculitis (HP:0002633) | 3.30904415 |
| 34 | Hypoproteinemia (HP:0003075) | 3.26541228 |
| 35 | Granulocytopenia (HP:0001913) | 3.26328431 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.25530858 |
| 37 | Lymphopenia (HP:0001888) | 3.24582063 |
| 38 | Leukocytosis (HP:0001974) | 3.24295640 |
| 39 | Abnormality of the prostate (HP:0008775) | 3.20436841 |
| 40 | Pustule (HP:0200039) | 3.18662929 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 3.15627773 |
| 42 | Recurrent viral infections (HP:0004429) | 3.09615086 |
| 43 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.09190957 |
| 44 | Joint swelling (HP:0001386) | 3.06332010 |
| 45 | Chronic obstructive pulmonary disease (HP:0006510) | 3.05970274 |
| 46 | Obstructive lung disease (HP:0006536) | 3.05970274 |
| 47 | Abnormality of macrophages (HP:0004311) | 3.05484708 |
| 48 | Hemoptysis (HP:0002105) | 2.93834478 |
| 49 | IgM deficiency (HP:0002850) | 2.83130170 |
| 50 | Hypergammaglobulinemia (HP:0010702) | 2.82676151 |
| 51 | Keratoconjunctivitis sicca (HP:0001097) | 2.81040257 |
| 52 | Chest pain (HP:0100749) | 2.78480121 |
| 53 | Keratoconjunctivitis (HP:0001096) | 2.73722895 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.73363852 |
| 55 | Recurrent skin infections (HP:0001581) | 2.71600210 |
| 56 | Gangrene (HP:0100758) | 2.70346792 |
| 57 | B lymphocytopenia (HP:0010976) | 2.63041654 |
| 58 | Pulmonary embolism (HP:0002204) | 2.62641743 |
| 59 | Agammaglobulinemia (HP:0004432) | 2.62239263 |
| 60 | Autoimmune thrombocytopenia (HP:0001973) | 2.57365877 |
| 61 | 3-Methylglutaconic aciduria (HP:0003535) | 2.54543427 |
| 62 | Abnormality of B cell number (HP:0010975) | 2.51806697 |
| 63 | Inflammation of the large intestine (HP:0002037) | 2.51782417 |
| 64 | Hypoplasia of the thymus (HP:0000778) | 2.51234217 |
| 65 | Lymphoma (HP:0002665) | 2.35972788 |
| 66 | Abnormality of the pleura (HP:0002103) | 2.35091067 |
| 67 | Gastrointestinal inflammation (HP:0004386) | 2.31452103 |
| 68 | Alveolar cell carcinoma (HP:0006519) | 2.29376188 |
| 69 | Increased IgE level (HP:0003212) | 2.28945438 |
| 70 | Bronchitis (HP:0012387) | 2.26600843 |
| 71 | Attenuation of retinal blood vessels (HP:0007843) | 2.12343747 |
| 72 | Recurrent otitis media (HP:0000403) | 2.11416567 |
| 73 | Spontaneous hematomas (HP:0007420) | 2.09922344 |
| 74 | Microcytic anemia (HP:0001935) | 2.06047945 |
| 75 | Anorexia (HP:0002039) | 2.04614320 |
| 76 | Oral leukoplakia (HP:0002745) | 2.04222039 |
| 77 | Petechiae (HP:0000967) | 2.00832644 |
| 78 | Abnormality of male internal genitalia (HP:0000022) | 1.99860967 |
| 79 | Pulmonary fibrosis (HP:0002206) | 1.99674959 |
| 80 | Ureteral stenosis (HP:0000071) | 1.98426928 |
| 81 | Keratitis (HP:0000491) | 1.98348279 |
| 82 | Pancytopenia (HP:0001876) | 1.96906232 |
| 83 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.96488782 |
| 84 | Ureteral obstruction (HP:0006000) | 1.93452012 |
| 85 | Epistaxis (HP:0000421) | 1.93434611 |
| 86 | Hypochromic anemia (HP:0001931) | 1.92969189 |
| 87 | Glomerulopathy (HP:0100820) | 1.92507726 |
| 88 | Prostate neoplasm (HP:0100787) | 1.89441738 |
| 89 | Skin rash (HP:0000988) | 1.86654831 |
| 90 | Abnormality of the pericardium (HP:0001697) | 1.80973654 |
| 91 | Polyneuropathy (HP:0001271) | 1.80442038 |
| 92 | Arterial thrombosis (HP:0004420) | 1.77258529 |
| 93 | Chronic otitis media (HP:0000389) | 1.74711080 |
| 94 | IgA deficiency (HP:0002720) | 1.74478366 |
| 95 | Arthralgia (HP:0002829) | 1.74326159 |
| 96 | Recurrent sinusitis (HP:0011108) | 1.73442814 |
| 97 | Verrucae (HP:0200043) | 1.71903312 |
| 98 | Papilloma (HP:0012740) | 1.71903312 |
| 99 | Increased intramyocellular lipid droplets (HP:0012240) | 1.71512968 |
| 100 | Hematochezia (HP:0002573) | 1.71471499 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 6.60982602 |
| 2 | MAP4K1 | 4.91418518 |
| 3 | FES | 3.09936753 |
| 4 | KDR | 2.96417283 |
| 5 | TAOK3 | 2.92328739 |
| 6 | ITK | 2.74559189 |
| 7 | TESK2 | 2.52279197 |
| 8 | TLK1 | 2.47487748 |
| 9 | ZAP70 | 2.40656340 |
| 10 | TNK2 | 2.32143407 |
| 11 | CSK | 2.23782382 |
| 12 | RIPK4 | 2.18341277 |
| 13 | CAMKK2 | 2.07733314 |
| 14 | TYK2 | 1.97370978 |
| 15 | GRK6 | 1.97071206 |
| 16 | ZAK | 1.95547201 |
| 17 | IKBKE | 1.94173194 |
| 18 | SYK | 1.88533945 |
| 19 | LCK | 1.85705000 |
| 20 | BTK | 1.83555575 |
| 21 | MAP3K11 | 1.76670207 |
| 22 | TEC | 1.75058678 |
| 23 | PASK | 1.67449830 |
| 24 | MST4 | 1.65111304 |
| 25 | JAK3 | 1.50989114 |
| 26 | JAK1 | 1.47638233 |
| 27 | TAOK2 | 1.42854188 |
| 28 | HCK | 1.42377264 |
| 29 | CAMKK1 | 1.36003039 |
| 30 | TYRO3 | 1.35700213 |
| 31 | MAP3K12 | 1.34587526 |
| 32 | PRKCQ | 1.29710341 |
| 33 | CSF1R | 1.28182380 |
| 34 | NLK | 1.25757594 |
| 35 | LYN | 1.25692743 |
| 36 | TAOK1 | 1.17449981 |
| 37 | SIK3 | 1.15373691 |
| 38 | IRAK4 | 1.12925305 |
| 39 | PIM1 | 1.03197257 |
| 40 | IKBKB | 1.02325905 |
| 41 | MARK3 | 1.00245872 |
| 42 | GRK7 | 0.99135744 |
| 43 | KIT | 0.98378440 |
| 44 | MAPKAPK3 | 0.97990049 |
| 45 | PRPF4B | 0.97698138 |
| 46 | JAK2 | 0.97066151 |
| 47 | SCYL2 | 0.94886732 |
| 48 | ADRBK2 | 0.94247346 |
| 49 | MAP2K6 | 0.84479554 |
| 50 | STK10 | 0.81641057 |
| 51 | MAP3K3 | 0.76293836 |
| 52 | MAPK11 | 0.75341383 |
| 53 | CDK4 | 0.70790523 |
| 54 | TBK1 | 0.70372273 |
| 55 | MAP3K14 | 0.69961251 |
| 56 | FGFR4 | 0.68433041 |
| 57 | BMPR2 | 0.67291072 |
| 58 | TESK1 | 0.66946752 |
| 59 | FYN | 0.65816053 |
| 60 | SIK2 | 0.65327283 |
| 61 | PIK3CG | 0.64018040 |
| 62 | BLK | 0.62802731 |
| 63 | MATK | 0.61289660 |
| 64 | MAP3K13 | 0.61289164 |
| 65 | MAP3K5 | 0.59338057 |
| 66 | INSR | 0.52445036 |
| 67 | PDK1 | 0.49069373 |
| 68 | CLK1 | 0.48168958 |
| 69 | PDGFRB | 0.45920947 |
| 70 | ADRBK1 | 0.43892104 |
| 71 | MAP2K3 | 0.43673493 |
| 72 | WNK4 | 0.42596716 |
| 73 | IGF1R | 0.42000758 |
| 74 | TGFBR2 | 0.41980503 |
| 75 | MAP3K1 | 0.40765329 |
| 76 | TRPM7 | 0.40612859 |
| 77 | MAPKAPK2 | 0.37727184 |
| 78 | FGFR3 | 0.37014845 |
| 79 | VRK1 | 0.36295285 |
| 80 | LRRK2 | 0.30287165 |
| 81 | IRAK2 | 0.27913937 |
| 82 | PRKCH | 0.25889339 |
| 83 | RPS6KA5 | 0.24268927 |
| 84 | GRK5 | 0.20571656 |
| 85 | STK38 | 0.19798554 |
| 86 | EGFR | 0.19726147 |
| 87 | STK39 | 0.18482977 |
| 88 | RAF1 | 0.17423676 |
| 89 | MAPK13 | 0.16575510 |
| 90 | MAPK3 | 0.15932648 |
| 91 | ABL1 | 0.14493055 |
| 92 | NEK6 | 0.13629017 |
| 93 | PRKCA | 0.12809257 |
| 94 | MELK | 0.12145817 |
| 95 | EPHB1 | 0.11375629 |
| 96 | NTRK2 | 0.10737889 |
| 97 | FGR | 0.09939193 |
| 98 | CHUK | 0.09440390 |
| 99 | PRKCD | 0.09335812 |
| 100 | GRK1 | 0.08276849 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 6.86448258 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.97012539 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.71047204 |
| 4 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.59409508 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 3.40449486 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.10976469 |
| 7 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.87083487 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.77244122 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.57027935 |
| 10 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.51944046 |
| 11 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.45930757 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.12807124 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.96634481 |
| 14 | Proteasome_Homo sapiens_hsa03050 | 1.95151359 |
| 15 | Viral myocarditis_Homo sapiens_hsa05416 | 1.84092588 |
| 16 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.83283689 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72139311 |
| 18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.60864067 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.56994095 |
| 20 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.52455487 |
| 21 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.44836722 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.36933335 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.34461061 |
| 24 | Leishmaniasis_Homo sapiens_hsa05140 | 1.30381985 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.28564050 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.24733184 |
| 27 | Asthma_Homo sapiens_hsa05310 | 1.22359663 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17074180 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.11443008 |
| 30 | Shigellosis_Homo sapiens_hsa05131 | 1.11266745 |
| 31 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11060459 |
| 32 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10976301 |
| 33 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.07638707 |
| 34 | Malaria_Homo sapiens_hsa05144 | 1.06419801 |
| 35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.05796458 |
| 36 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.03950153 |
| 37 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.01299505 |
| 38 | Ribosome_Homo sapiens_hsa03010 | 0.89564890 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.84759349 |
| 40 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82724155 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79785294 |
| 42 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.79178342 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 0.79142306 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78872568 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 0.77937026 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77702314 |
| 47 | Hepatitis B_Homo sapiens_hsa05161 | 0.77255784 |
| 48 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73279909 |
| 49 | Influenza A_Homo sapiens_hsa05164 | 0.71364886 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64601000 |
| 51 | Apoptosis_Homo sapiens_hsa04210 | 0.64103078 |
| 52 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63303999 |
| 53 | RNA polymerase_Homo sapiens_hsa03020 | 0.62567986 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.61938891 |
| 55 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.61588759 |
| 56 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61346928 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.59793874 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55203413 |
| 59 | Endocytosis_Homo sapiens_hsa04144 | 0.53559393 |
| 60 | Salmonella infection_Homo sapiens_hsa05132 | 0.51926561 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.51380935 |
| 62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.51265058 |
| 63 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50516212 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.48365913 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47033531 |
| 66 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46382546 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43214948 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43070926 |
| 69 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.39603145 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 0.38280081 |
| 71 | Parkinsons disease_Homo sapiens_hsa05012 | 0.35585239 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32545328 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.32001328 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.30469511 |
| 75 | Olfactory transduction_Homo sapiens_hsa04740 | 0.28186187 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.23727107 |
| 77 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23045348 |
| 78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22633987 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.22480620 |
| 80 | Phagosome_Homo sapiens_hsa04145 | 0.22251071 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.21161053 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.21133453 |
| 83 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.21127792 |
| 84 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.20819619 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.17855101 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.17117637 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15652789 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14261621 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.13990756 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.13567410 |
| 91 | Spliceosome_Homo sapiens_hsa03040 | 0.13070467 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.12775322 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.10995452 |
| 94 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.07280515 |
| 95 | Peroxisome_Homo sapiens_hsa04146 | 0.07086988 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.06174472 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.02690148 |
| 98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.02361962 |
| 99 | Morphine addiction_Homo sapiens_hsa05032 | 0.02072913 |
| 100 | Long-term potentiation_Homo sapiens_hsa04720 | 0.01697659 |

